We are live on ! Find out more
OTC

Opera Trading Capital Portfolio holdings

AUM $419M
1-Year Est. Return 0.58%
This Fund
S&P 500
This Quarter Est. Return
-0.33%
1 Year Est. Return
+0.58%
3 Year Est. Return
+11.35%
5 Year Est. Return
10 Year Est. Return
AUM
$419M
AUM Growth
-$111M
Cap. Flow
-$328M
Cap. Flow %
-78.26%
Top 10 Hldgs %
38.61%
Holding
196
New
19
Increased
10
Reduced
16
Closed
109
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
URBN icon
126
Urban Outfitters
URBN
$6.25B
-3,000
Closed -$123K
USA icon
127
Liberty All-Star Equity Fund
USA
$1.77B
-15,628
Closed -$106K
VEU icon
128
Vanguard FTSE All-World ex-US ETF
VEU
$65.6B
-700
Closed -$36K
VRTX icon
129
Vertex Pharmaceuticals
VRTX
$123B
-1,807
Closed -$348K
VST icon
130
Vistra
VST
$52.4B
-100
Closed -$2K
VYGR icon
131
Voyager Therapeutics
VYGR
$192M
-2,474
Closed -$47K
WMT icon
132
Walmart Inc
WMT
$909B
-15,600
Closed -$488K
WVE icon
133
Wave Life Sciences
WVE
$1.12B
-1,150
Closed -$58K
LGF.B
134
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
-13,288
Closed -$310K
ITCI
135
DELISTED
Intra-Cellular Therapies Inc.
ITCI
-2,954
Closed -$64K
LSXMA
136
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
-8,223
Closed -$258K
SPLK
137
DELISTED
Splunk Inc
SPLK
-45
Closed -$5K
ICPT
138
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
-448
Closed -$57K
MYOV
139
DELISTED
Myovant Sciences Ltd.
MYOV
-4,417
Closed -$117K
RDUS
140
DELISTED
Radius Health, Inc.
RDUS
-15,459
Closed -$275K
DISCK
141
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
-80,101
Closed -$2.37M
IFFT
142
DELISTED
International Flavors & Fragrances Inc. 6.00% Tangible Equity Units
IFFT
-155,000
Closed -$8.21M
ALXN
143
DELISTED
Alexion Pharmaceuticals
ALXN
-2,002
Closed -$278K
FPRX
144
DELISTED
Five Prime Therapeutics, Inc.
FPRX
-1,582
Closed -$22K
GLIBA
145
DELISTED
GCI Liberty, Inc. Class A Common Stock (DE)
GLIBA
-10,392
Closed -$530K
AKCA
146
DELISTED
Akcea Therapeutics Inc
AKCA
-1,818
Closed -$64K
ACHN
147
DELISTED
Achillion Pharmaceuticals
ACHN
-2,106
Closed -$8K
ALDR
148
DELISTED
Alder Biopharmaceuticals
ALDR
-2,990
Closed -$50K
LEXEA
149
DELISTED
Liberty Expedia Holdings, Inc. Class A Common Stock
LEXEA
-20,963
Closed -$986K
NITE
150
DELISTED
Nightstar Therapeutics plc American Depositary Shares
NITE
-2,000
Closed -$41K

Similar funds

Opera Trading Capital's Q4 2018 Portfolio in Review

As of Q4 2018, Opera Trading Capital held 196 positions worth $419M, down 21% from $530M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Opera Trading Capital withdrew a net $328M in Q4 2018, closing 109 positions and reducing 16 holdings. Its most notable exit was Hess Corporation, an estimated $8.63M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 2.2% of assets, up from 1.1% a quarter earlier, followed by Healthcare and Real Estate.

Against the trend, Opera Trading Capital opened a new position in Fortive Corporation 5.00% Mandatory Convertible Preferred Stock, Series A worth $11.8M.

  • Opera Trading Capital's largest Q4 2018 buy was Fortive Corporation 5.00% Mandatory Convertible Preferred Stock, Series A: 13,000 shares worth $11.8M.
  • Opera Trading Capital added most to SodaStream International Ltd in Q4 2018, an estimated $6.34M increase.
  • Opera Trading Capital's biggest Q4 2018 reduction was DTE Energy Company 2016 Corporate Units, cutting an estimated $8.01M.
  • Opera Trading Capital fully exited Hess Corporation in Q4 2018, selling an estimated $8.63M.
  • Opera Trading Capital's ten largest holdings make up 39% of its $419M portfolio in Q4 2018.
  • Opera Trading Capital opened 19 new positions and closed 109 in Q4 2018.
  • Opera Trading Capital's portfolio value fell 21% quarter-over-quarter to $419M.

Based on Opera Trading Capital's 13F filing for Q4 2018, filed 22 Jan 2019.